Ownership and insider activity for Biofrontera Inc. (BFRI): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Price
| Price | $1.21 |
| Market Cap | $15M |
| Exchange | NASDAQ |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-07-28 | Luebbert Hermann | M-Exempt | 62,500 | |
| 2026-07-28 | Luebbert Hermann | M-Exempt | 62,500 | |
| 2026-07-28 | Leffler Eugene Frederick | M-Exempt | 31,250 | |
| 2026-07-28 | Leffler Eugene Frederick | M-Exempt | 31,250 | |
| 2026-03-04 | Weber Kevin Daniel | A-Award | 20,000 | $18K |
| 2026-03-05 | Luebbert Hermann | M-Exempt | 137,500 | |
| 2026-03-04 | Luebbert Hermann | A-Award | 125,000 | |
| 2026-03-04 | Luebbert Hermann | A-Award | 125,000 | $112K |
| 2026-03-05 | Luebbert Hermann | M-Exempt | 137,500 | |
| 2026-03-05 | Leffler Eugene Frederick | M-Exempt | 87,500 |
Balance Sheet (10y)
| Year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7.3M | $8.1M | $24.5M | $17.2M | $1.3M | $5.9M | $6.4M |
| Short-term Investments | 0 | 0 | 0 | $10.5M | $78000 | $7000 | $9000 |
| Receivables | $4.8M | $3.3M | $3.8M | $7.4M | $5.2M | $5.3M | $7.3M |
| Inventory | $10.5M | $7.1M | $4.5M | $7.2M | $10.9M | $6.6M | $1.4M |
| Total Current Assets | $23.5M | $19.6M | $46.4M | $43.1M | $23.1M | $20.7M | $18.1M |
| Property, Plant & Equipment | $503000 | $370000 | $267000 | $1.6M | $1.7M | $983000 | $3.7M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | $4.3M | $3.9M | $3.5M | $3.0M | $2.6M | $35000 | $2.6M |
| Total Assets | $28.8M | $24.1M | $53.2M | $50.9M | $27.9M | $22.1M | $28.6M |
| Accounts Payable | $7.8M | $1.5M | $658000 | $1.3M | $8.9M | $1.9M | $1.9M |
| Short-term Debt | 0 | 0 | 0 | 0 | $3.9M | 0 | 0 |
| Total Current Liabilities | $11.7M | $4.4M | $13.8M | $20.9M | $18.1M | $12.0M | $11.9M |
| Long-term Debt | $38.2M | 0 | 0 | 0 | 0 | $4.1M | $5.8M |
| Total Liabilities | $58.9M | $18.3M | $41.9M | $27.0M | $23.1M | $17.7M | $18.1M |
| Retained Earnings | -$30.2M | -$41.2M | -$78.9M | -$79.5M | -$99.7M | -$117.4M | -$127.9M |
| Total Equity | -$30.2M | $5.8M | $11.3M | $23.9M | $4.8M | $4.4M | $10.5M |
| Total Debt | $38.2M | 0 | 0 | $1.3M | $5.4M | $4.9M | $6.2M |
| Net Debt | $30.9M | -$8.1M | -$24.5M | -$26.4M | $4.0M | -$990000 | -$231000 |
| Working Capital | $11.7M | $15.2M | $32.6M | $22.2M | $5.0M | $8.7M | $6.2M |
Financial Health
| Debt / Equity | 1.26 |
| Current Ratio | 1.18 |
Profitability
| Return on Equity | -127.78% |
| Return on Invested Capital | -31.18% |
| Return on Assets | -26.45% |
| Gross Margin | 84.45% |
| Operating Margin | -9.45% |
| Net Margin | -13.78% |
Related companies: AYTU · COCP · DWTX · EVGN · GELS · IMNN · PRPH
Explore sector: Healthcare · Medical - Pharmaceuticals
More sections of BFRI: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks